Literature DB >> 27630921

Clinical Relevance of Single-Voxel (1)H MRS Metabolites in Discriminating Suprasellar Tumors.

A Einstien1, Rahul A Virani2.   

Abstract

INTRODUTION: Spatially resolved metabolic data obtained from Proton Magnetic Resonance Spectroscopy ((1)H MRS) provides information which increases the diagnostic accuracy of imaging sequences in predicting the histology of suprasellar tumors. AIM: To evaluate the role of (1)H MRS in the diagnosis of various suprasellar tumors.
MATERIALS AND METHODS: Sixty cases of various suprasellar, hypothalamic and third ventricular neoplasms were investigated with long-echo single voxel (1)H -MRS using 1.5 Tesla clinical imager. Single-voxel spectroscopic examinations were guided by T1-weighted or T2-weighted images. Statistical analysis was carried out using IBM SPSS software version 19.
RESULTS: We observed that whenever brain tissue was damaged or replaced by any process, NAA was markedly reduced. Extra-axial lesions which do not infiltrate brain or contain neuroglial tissue, didn't demonstrate any NAA resonances. Cr was used as an internal standard for semi-quantitative evaluation of metabolic changes of other brain metabolites. Increased Cho was seen in processes with elevated cell-membrane turnover.
CONCLUSION: Spectra obtained from different tumors exhibit reproducible differences while histologically similar tumors yield characteristic spectra with only minor differences. Pituitary tumors were typically characterized by significant reduction of NAA, Cr peak and moderate elevation of Cho peak. Gliomas were typically characterized by decrease of NAA and Cr peaks and increase of Cho peak. Craniopharyngiomas were typically characterized by significant decrease of all metabolites.

Entities:  

Keywords:  Choline; Creatine; N-acetylaspartate; Spectroscopy

Year:  2016        PMID: 27630921      PMCID: PMC5020211          DOI: 10.7860/JCDR/2016/17988.8078

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

1.  Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database.

Authors:  Margarida Julià-Sapé; Dionisio Acosta; Carles Majós; Angel Moreno-Torres; Pieter Wesseling; Juan José Acebes; John R Griffiths; Carles Arús
Journal:  J Neurosurg       Date:  2006-07       Impact factor: 5.115

2.  Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives.

Authors:  A Falini; G Calabrese; D Origgi; S Lipari; F Triulzi; M Losa; G Scotti
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

Review 3.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

Review 4.  Imaging of sellar and parasellar lesions.

Authors:  Janine Rennert; Arnd Doerfler
Journal:  Clin Neurol Neurosurg       Date:  2006-11-28       Impact factor: 1.876

Review 5.  Clinical applications of proton MR spectroscopy in oncology.

Authors:  Lester Kwock; J Keith Smith; Mauricio Castillo; Matthew G Ewend; Sharon Cush; Thomas Hensing; Mahesh Varia; David Morris; Thomas W Bouldin
Journal:  Technol Cancer Res Treat       Date:  2002-02

6.  Possible role of single-voxel (1)H-MRS in differential diagnosis of suprasellar tumors.

Authors:  Mikhail F Chernov; Takakazu Kawamata; Kosaku Amano; Yuko Ono; Takashi Suzuki; Ryoichi Nakamura; Yoshihiro Muragaki; Hiroshi Iseki; Osami Kubo; Tomokatsu Hori; Kintomo Takakura
Journal:  J Neurooncol       Date:  2008-09-30       Impact factor: 4.130

7.  Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin.

Authors:  Mikhail F Chernov; Yuko Ono; Osami Kubo; Tomokatsu Hori
Journal:  Brain Tumor Pathol       Date:  2006-04       Impact factor: 3.298

8.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.

Authors:  H Bruhn; J Frahm; M L Gyngell; K D Merboldt; W Hänicke; R Sauter; C Hamburger
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

9.  Imaging of the pituitary: Recent advances.

Authors:  Vikas Chaudhary; Shahina Bano
Journal:  Indian J Endocrinol Metab       Date:  2011-09

Review 10.  Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.

Authors:  Gigin Lin; Yuen-Li Chung
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

View more
  4 in total

1.  Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions.

Authors:  Navzer D Sachinvala; Angeline Stergiou; Duane E Haines
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-04       Impact factor: 2.570

2.  Proton Magnetic Resonance Spectroscopy Characterization of Rathke's Cleft Cysts (RCCs): Relevance to the Differential Diagnosis of Pituitary Adenomas and RCCs.

Authors:  Omkar B Ijare; Martyn A Sharpe; David S Baskin; Kumar Pichumani
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

Review 3.  Metabolomics-A Promising Approach to Pituitary Adenomas.

Authors:  Oana Pînzariu; Bogdan Georgescu; Carmen E Georgescu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-17       Impact factor: 5.555

4.  Post-Craniopharyngioma and Cranial Nerve-VI Palsy Update on a MS Patient with Major Depression and Concurrent Neuroimmune Conditions.

Authors:  Navzer D Sachinvala; Angeline Stergiou; Duane E Haines; Armen Kocharian; Andrew Lawton
Journal:  Brain Sci       Date:  2019-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.